ArticleBMC infectious diseases2024

A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital.

Hao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.